Immune Checkpoint Inhibitors + Tyrosine Kinase Inhibitors for the Treatment of RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Combination of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for the Treatment of Renal Cell Carcinoma
Expert Opin Biol Ther 2021 Feb 12;[EPub Ahead of Print], V Stühler, S Rausch, JM Maas, A Stenzl, J BedkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.